Murray Raycroft
Analyst
Analyst — Jefferies
Earnings-call appearances
-
Intellia Therapeutics, Inc. Q4 FY2025 Earnings Call2026-02-26
Intellia Therapeutics, Inc. (NTLA)
-
Phase 3 VIKTORIA-1 HR+/HER2-/PIK3CA WT Trial Results Presentation2025-10-20
Celcuity Inc. (CELC)